Pascal Neuville, Domain Therapeutics CEO
Updated: A GPCR startup out of France and Canada scores its Series A after 14 years of wheeling and dealing
Having already nailed down multiple licensing and collaboration deals with Big Pharma giants like Bristol Myers Squibb and Pfizer, a France- and Quebec-based GPCR biotech …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.